Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections.

AUTOR(ES)

Piercy, E A

RESUMO

Thirty-seven patients with methicillin-resistant Staphylococcus aureus infections and/or colonization were treated with oral ciprofloxacin (750 mg twice a day). Clinical cure or improvement of infections occurred in 91% of the patients, and bacteriologic cure occurred in 60%. Ciprofloxacin therapy suppressed methicillin-resistant S. aureus colonization in 55% of the patients. Ciprofloxacin-resistant strains emerged in 6 of the 37 patients.

Documentos Relacionados

• Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations.
• Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.
• Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections.
• Methicillin-resistant Staphylococcus aureus.
• Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.